Therapeutic effects of mirodenafil, a phosphodiesterase 5 inhibitor, on stroke models in rats
Mirodenafil is a phosphodiesterase 5 (PDE5) inhibitor with high specificity for its target and good blood-brain barrier permeability. The drug, which is currently used for treatment of erectile dysfunction, reduces Aβ and pTau levels and improves cognitive function in mouse models of Alzheimer'...
Saved in:
| Main Authors: | Fred Kim, Padmanabh Singh, Hyunji Jo, Tianyang Xi, Dong-Keun Song, Sae Kwang Ku, Jai Jun Choung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Neurotherapeutics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924001508 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mirodenafil improves cognitive function by reducing microglial activation and blood–brain barrier permeability in ApoE4 KI mice
by: Yejin Park, et al.
Published: (2025-05-01) -
In vitro and In vivo Studies on Mesenchymal Stem Cells for Ischemic Stroke Therapy: A Scoping Review of The Therapeutic Effect
by: Rinendyaputri R, et al.
Published: (2025-05-01) -
Esculetin attenuates cerebral ischemia-reperfusion injury and protects neurons through Nrf2 activation in rats
by: Zhe Zhang, et al.
Published: (2024-11-01) -
Catalpalactone protects rats nerve function from hypoxic lesion by polarizing microglial cells toward M2 phenotype
by: Yu Wang, et al.
Published: (2025-02-01) -
ACUTE STROKE MODELS USED IN PRECLINICAL RESEARCH
by: I. N. Tyurenkov, et al.
Published: (2019-01-01)